News
Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled ...
'A crisis on our hands': California lawmakers scramble to find solutions for rising gas prices as departing oil refineries could cut supply by 20% — but some say it's a 'self-created' problem ...
Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...
Without warning or even a phone call, the Pediatric Interim Care Center in Kent, a resource for treating drug-exposed newborns, was cut off entirely from Washington state funds through a partial ...
Hims & Hers’ stock price has swung wildly this year. The telehealth company’s public feud with drugmaker Novo Nordisk knocked off a nearly a third of its valuation on Monday. On Friday, Hims ...
California Democrats aim to ease the state’s gasoline standards and streamline permitting for refineries in a bid to prevent more fuelmakers from shutting down.
A key inflation gauge moved higher in May in the latest sign that prices remain stubbornly elevated while Americans cut back on their spending.
Leeds can land cut-price deal for Lyon’s Georges Mikautadze The recent announcement around football was the confirmed relegation of French side Lyon to Ligue 2. It certainly took many by surprise, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results